Pulmatrix
PULM
$1.95
Share price
2.63%
Change (1 day)
-27.24%
Change (1 year)
Categories
Pulmatrix (PULM) - P/B ratio
P/B ratio as of June 2024 : 0.3745
According to Pulmatrix's latest financial reports the company has a price-to-book ratio of 0.3745.
The price-to-book ratio is a way to measure how much the stock market thinks a company is worth compared to how much the company says its assets are worth on paper.
Pulmatrix - P/B ratio (from 2014 to 2024)
P/B ratio by year
| Year | P/B ratio | Change |
|---|---|---|
| 2024-12-31 | N/A | -100% |
| 2023-12-31 | 0.3775 | -16.83% |
| 2022-12-31 | 0.4539 | -12.5% |
| 2021-12-31 | 0.5188 | -70.68% |
| 2020-12-31 | 1.77 | 13.39% |
| 2019-12-31 | 1.56 | 56.06% |
| 2018-12-31 | 1.0000 | -65.84% |
| 2017-12-31 | 2.93 | 195.7% |
| 2016-12-31 | 0.9901 | -47.88% |
| 2015-12-31 | 1.90 | 27.63% |
| 2014-12-31 | 1.49 | |
| 2013-12-31 | N/A |
P/B ratio for similar companies or competitors
| Company | P/B ratio | differencediff. | Country |
|---|---|---|---|
 Pieris Pharmaceuticals PIRS | 0.5236 | 39.81% | 🇺🇸 USA |
 OPKO Health
OPK | 0.7177 | 91.65% | 🇺🇸 USA |
 Blueprint Medicines
BPMC | 21.5 | 5,634.40% | 🇺🇸 USA |